Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I

Journal of the American College of Cardiology

Volumn 74, Issue 3, 2019, Pages 271-282

  Sandoval, Y ^a   Nowak, Richard ^b   deFilippi, Christopher R ^c   Christenson, Robert H ^d   Peacock, W Frank ^e   McCord, J ^f   Limkakeng, Alexander T ^g   Sexter, Anne ^h   Apple, Fred S ^i,j  

^a MAYO CLINIC   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c INOVA HEART AND VASCULAR INSTITUTE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f HENRY FORD HOSPITAL   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

ⁱ HENNEPIN COUNTY MEDICAL CENTER   (United States)

^j UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

more..

Author keywords

acute myocardial infarction; high sensitivity cardiac troponin; risk stratification; troponin

Indexed keywords

HIGH SENSITIVITY CARDIAC TROPONIN I; TROPONIN I; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; FEMALE; HEART DEATH; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PATIENT IDENTIFICATION; PATIENT SAFETY; PREDICTIVE VALUE; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; AGED; BLOOD; CLINICAL TRIAL; HEART INFARCTION; MULTICENTER STUDY; PROSPECTIVE STUDY;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 85068265806     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2019.05.058     Document Type: Article

References (25)

1. Thygesen, K., Alpert, J.S., Jaffe, A.S., et al., Executive Group on Behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 72 (2018), 2231–2264.
2. Twerenbold, R., Boeddinghaus, J., Nestelberger, T., et al. Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction. J Am Coll Cardiol 70 (2017), 996–1012.
3. Januzzi, J.L., Mahler, S.A., Christenson, R.H., et al. Recommendations for institutions transitioning to high-sensitivity troponin test: JACC Scientific Expert Panel. J Am Coll Cardiol 73 (2019), 1059–1077.
4. Sandoval, Y., Smith, S.W., Apple, F.S., Present and future of cardiac troponin in clinical practice: a paradigm shift to high-sensitivity assays. Am J Med 129 (2016), 354–365.
5. Apple, F.S., Sandoval, Y., Jaffe, A.S., Ordonez-Llanos, J., IFCC Task Force on Clinical Applications of Cardiac Bio-markers. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem 63 (2017), 73–81.
6. Wu, A.H.B., Christenson, R.H., Greene, D.N., et al. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem 64 (2018), 645–655.
7. Hamm, C.W., Bassand, J.P., Agewall, S., et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the Management of Acute Coronary Syndromes (ACS) in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 32 (2011), 2999–3054.
8. Roffi, M., Patrono, C., Collet, J.P., et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Hear J 37 (2016), 267–315.
9. Chapman, A.R., Lee, K.K., McAllister, D.A., et al. Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome. JAMA 318 (2017), 1913–1924.
10. Pickering, J.W., Than, M.P., Cullen, L., et al. Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis. Ann Intern Med 166 (2017), 715–724.
11. Sandoval, Y., Smith, S.W., Love, S.A., Sexter, A., Schulz, K., Apple, F.S., Single high-sensitivity cardiac troponin I to rule out acute myocardial infarction. Am J Med 139 (2017), 1076–1083.
12. Sandoval, Y., Jaffe, A.S., Using high-sensitivity cardiac troponin T for acute cardiac care. Am J Med 130 (2017), 1358–1365.
13. Peacock, W.F., Baumann, B.M., Bruton, D., et al. Efficacy of high-sensitivity troponin T in identifying very-low-risk patients with possible acute coronary syndrome. JAMA Cardiol 3 (2018), 104–111.
14. McRae, A.D., Innes, G., Graham, M., et al. Undetectable concentrations of a Food and Drug Administration–approved high-sensitivity cardiac troponin T assay to rule out acute myocardial infarction at emergency department arrival. Acad Emerg Med 24 (2017), 1267–1277.
15. Christenson, R.H., Peacock, W.F., Apple, F.S., et al. Trial design for assessing and clinical performance of high-sensitivity cardiac troponin I assays in the United States: the HIGH US study. Contemp Clin Trials Commun, 14, 2019, 100337.
16. International Federation of Clinical Chemistry and Laboratory Medicine. High-Sensitivity* Cardiac Troponin I and T Assay Analytical Characteristics Designated by Manufacturer: IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB) v012019. Available at: http://www.ifcc.org/media/477656/high-sensitivity-cardiac-troponin-i-and-t-assay-analytical-characteristics-designated-by-manufacturer-v012019.pdf. (Accessed 19 February 2019)
17. ADVIA Centaur and Atellica IM high-sensitivity cardiac troponin I assays manufacturers’ package inserts. Available at: https://doclib.healthcare.siemens.com/home. (Accessed 19 February 2019)
18. Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 60 (2012), 1581–1598.
19. American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Suspected Non-ST-Elevation Acute Coronary Syndromes Tomaszewski, C.A., Nester, D., Shah, K.H., Sudhir, A., Brown, M.D., Clinical policy: critical issues in the evaluation and management of emergency department patients with suspected non-ST-elevation acute coronary syndromes. Ann Emerg Med 72 (2018), e65–e106.
20. Chapman, A.R., Fujisawa, T., Lee, K.K., et al. Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome. Heart 105 (2019), 616–622.
21. Boeddinghaus, J., Twerenbold, R., Nestelberger, T., et al. Clinical validation of a novel high-sensitivity cardiac troponin I assay for early diagnosis of acute myocardial infarction. Clin Chem 64 (2018), 1347–1360.
22. Shah, A.S., Anand, A., Sandoval, Y., et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 386 (2015), 2481–2488.
23. Eggers, K.M., Jernberg, T., Ljung, L., Lindahl, B., High-sensitivity cardiac troponin-based strategies for the assessment of chest pain patients – a review of validation and clinical implementation studies. Clin Chem 64 (2018), 1572–1585.
24. Carlton, E., Campbell, S., Ingram, J., et al. Randomised controlled trial of the Limit of Detection of Troponin and ECG Discharge (LoDED) strategy versus usual care in adult patients with chest pain attending the emergency department: study protocol. BMJ Open, 8, 2018, e025339.
25. HighSTEACS: High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome. Available at: https://highsteacs.com. (Accessed 20 March 2019)